Sinopep Allsino Bio Pharmaceutical Co Ltd Class A 688076
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥60.94
- Day Range
- ¥61.01–69.63
- 52-Week Range
- ¥19.94–81.50
- Bid/Ask
- ¥68.78 / ¥68.79
- Market Cap
- ¥15.12 Bil
- Volume/Avg
- 9.6 Mil / 4.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 43.14
- Price/Sales
- 10.44
- Dividend Yield (Trailing)
- 0.73%
- Dividend Yield (Forward)
- 0.73%
- Total Yield
- 0.73%
Company Profile
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,545
- Website
- http://www.sinopep.com.cn
Comparables
Valuation
|
Metric
|
688076
|
301207
|
688278
|
|---|---|---|---|
Price/Earnings (Normalized) | 43.14 | 17.92 | 42.95 |
Price/Book Value | 6.18 | 2.11 | 14.47 |
Price/Sales | 10.44 | 5.45 | 12.19 |
Price/Cash Flow | 23.48 | 13.22 | 38.93 |
Price/Earnings
688076
301207
688278
Financial Strength
|
Metric
|
688076
|
301207
|
688278
|
|---|---|---|---|
Quick Ratio | 0.98 | 2.85 | 3.14 |
Current Ratio | 1.37 | 3.42 | 4.07 |
Interest Coverage | 17.43 | 149.96 | 1,553.17 |
Quick Ratio
688076
301207
688278
Profitability
|
Metric
|
688076
|
301207
|
688278
|
|---|---|---|---|
Return on Assets (Normalized) | 10.45% | 9.24% | 30.63% |
Return on Equity (Normalized) | 16.43% | 11.52% | 37.49% |
Return on Invested Capital (Normalized) | 12.34% | 10.82% | 37.06% |
Return on Assets
688076
301207
688278
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Fhjrnvwmp | Xnkp | $512.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Yvgxpnw | Xqtvvb | $117.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Pvtlwhhdz | Rskry | $111.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Cjmybzg | Hhjctcz | $34.4 Bil | |||
| argenx SE ADR
ARGX
| Fwgxjpq | Bgmj | $31.7 Bil | |||
| BioNTech SE ADR
BNTX
| Ljgwfwrmv | Tvbr | $29.2 Bil | |||
| Moderna Inc
MRNA
| Hjytgtkp | Gqts | $23.1 Bil | |||
| United Therapeutics Corp
UTHR
| Jcgnpylr | Ymp | $15.8 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Bddcrxl | Dpqkbf | $13.2 Bil | |||
| Incyte Corp
INCY
| Mjxtrnfm | Frwlhr | $13.0 Bil |
United States